Nephropathic Cystinosis

← Back to Class List

Drug Use Review Documents

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
cysteamine bitartrate PROCYSBI CAP DR SPR PA Document Mar 27, 2014
cysteamine bitartrate CYSTAGON CAPSULE   Mar 27, 2014
cysteamine bitartrate PROCYSBI GRANDR PKT PA Document Mar 27, 2014